TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8732492

Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: D-arginine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-lysine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: D-lysine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ornithine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hyperosmolar sodium chloride
Number of subjects: 8
Study: 1553671

Group type: EXPERIMENTAL
Intervention: 2.5 mg trinitroglycerine patches
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 81
Study: 2991171

Group type: EXPERIMENTAL
Intervention: Extruded whole-grain product
Number of subjects: 9

Group type: COMPARATOR
Intervention: Baked whole-grain wheat bread
Number of subjects: 9

Group type: COMPARATOR
Intervention: White bread
Number of subjects: 9

Group type: COMPARATOR
Intervention: Extruded crispbread-like products (white and whole-grain)
Number of subjects: 9
Study: 31087715

Group type: EXPERIMENTAL
Intervention: Any antibiotics use
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Antibiotics for respiratory infections
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Antibiotics for urinary tract infections
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Antibiotics for skin and soft tissue infections
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Beta-lactamase sensitive penicillin (more than two prescriptions)
Number of subjects: 2484
Study: 29161674

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subcallosal cingulate gyrus (SCG)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 8
Study: 27648792

Group type: EXPERIMENTAL
Intervention: Ice/gel pack cryotherapy wrap
Number of subjects: 100

Group type: COMPARATOR
Intervention: Circulating cold water cryotherapy device
Number of subjects: 100
Study: 23489253

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/daily)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 21762564

Group type: EXPERIMENTAL
Intervention: Conventional chest physical therapy (CCPT)
Number of subjects: 280

Group type: COMPARATOR
Intervention: High-frequency chest wall compressions (HFCWC)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Both CCPT and HFCWC
Number of subjects: 280
Study: 20466215

Group type: EXPERIMENTAL
Intervention: AutoPulse‐CPR
Number of subjects: 0

Group type: COMPARATOR
Intervention: manual‐CPR
Number of subjects: 0
Study: 18249290

Group type: EXPERIMENTAL
Intervention: Bionator
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Headgear/Bite Plane
Number of subjects: 208

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 208
Study: 16182705

Group type: EXPERIMENTAL
Intervention: Single Kidney Graft (SKG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dual Kidney Graft (DKG)
Number of subjects: 60
Study: 10556650

Group type: EXPERIMENTAL
Intervention: Patients with psoriasis
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy age‐matched controls
Number of subjects: 34
Study: 8907098

Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 264

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 264
Study: 29683498

Group type: EXPERIMENTAL
Intervention: A‐PRF
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: A‐PRF+FDBA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: FDBA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Blood clot
Number of subjects: 40
Study: 25787020

Group type: EXPERIMENTAL
Intervention: Losartan (mean 43 ± 12 mg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 24411152

Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 22
Study: 24223343

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 104

Group type: COMPARATOR
Intervention: Dexamethasone 8 mg
Number of subjects: 104
Study: 20160397

Group type: EXPERIMENTAL
Intervention: 15 mg/day pioglitazone for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: 500 mg/day metformin for 12 weeks
Number of subjects: 50
Study: 17089155

Group type: EXPERIMENTAL
Intervention: Microwave diathermy treatment (passive hyperthermia) increasing muscle temperature to over 40 degrees C, 16-20 hours prior to exercise.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control arm (untreated)
Number of subjects: 15
Study: 16307999

Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 30
Study: 12219338

Group type: EXPERIMENTAL
Intervention: Self-information booklet (SIB) with paroxetine (Group A)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Paroxetine alone (Group B)
Number of subjects: 84
Study: 9459227

Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (fentanyl and midazolam)
Number of subjects: 44
Study: 7876412

Group type: EXPERIMENTAL
Intervention: Direct resin composite (DC) veneer restorations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indirect resin composite (IC) veneer restorations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Porcelain (P) veneer restorations
Number of subjects: 0
Study: 2404033

Group type: EXPERIMENTAL
Intervention: 0.02% chlorhexidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: water
Number of subjects: 10
Study: 351488

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 30796001

Group type: EXPERIMENTAL
Intervention: Grinding
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sandblasting
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Methyl methacrylate application
Number of subjects: 80

Group type: COMPARATOR
Intervention: Polycarbonate groups (all treatment methods)
Number of subjects: 80

Group type: COMPARATOR
Intervention: PMMA groups (all treatment methods)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both crown materials
Number of subjects: 80
Study: 29020247

Group type: EXPERIMENTAL
Intervention: Arterolane maleate (AM) 37.5 mg and piperaquine phosphate (PQP) 187.5 mg once daily for 3 days
Number of subjects: 859

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) twice daily for 3 days
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Arterolane maleate (AM) and piperaquine phosphate (PQP)
Number of subjects: 859

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 859
Study: 24854088

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (clobetasol propionate 0.05% ointment) applied for the first 2 days, followed by petrolatum jelly for the rest of the week.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Petrolatum jelly applied for 7 days (control group).
Number of subjects: 40

Group type: COMPARATOR
Intervention: Petrolatum jelly (control group).
Number of subjects: 40
Study: 23829026

Group type: EXPERIMENTAL
Intervention: Monitoring critical signals with separated displays
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monitoring critical signals with split-screen displays
Number of subjects: 0

Group type: COMPARATOR
Intervention: No monitoring of critical signals
Number of subjects: 0
Study: 21729165

Group type: EXPERIMENTAL
Intervention: Topical 5-aminolevulinic acid (5-ALA) PDT at 25 mW/cm2
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Topical 5-aminolevulinic acid (5-ALA) PDT at 50 mW/cm2
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Topical 5-aminolevulinic acid (5-ALA) PDT at 75 mW/cm2
Number of subjects: 50
Study: 19657610

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 300

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 300
Study: 16253380

Group type: EXPERIMENTAL
Intervention: Multiple actrapid and NPH insulin injections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulphonylurea and metformin+/‐acarbose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rosiglitazone and glimepiride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study: 14967744

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (carboplatin 30 mg/m2 on days 1-5 of weeks 1, 3, and 5; radiotherapy 54.0 Gy to all risk volumes plus 10.0 Gy to high-risk volumes; 5 daily fractions of 1.8 Gy each per week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy
Number of subjects: 40
Study: 11051743

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (nitrosorbid, cardiket) 80 mg/day
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isosorbide 5‐mononitrate (mono mac) 51.5 mg/day
Number of subjects: 19
Study: 9610959

Group type: EXPERIMENTAL
Intervention: Fibrinogen measurement in fresh plasma samples
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fibrinogen measurement in frozen plasma samples stored at -70 degrees C
Number of subjects: 0
Study: 8223839

Group type: EXPERIMENTAL
Intervention: Controlled-release formulation containing metoprolol 100 mg and hydrochlorothiazide 12.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional combination tablet
Number of subjects: 0
Study: 3532593

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine b.i.d. (49 patients)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 300 mg ranitidine nocte (47 patients)
Number of subjects: 96
Study: 28890275

Group type: EXPERIMENTAL
Intervention: Web-based decision-training tool
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 151
Study: 26524709

Group type: EXPERIMENTAL
Intervention: Undetectable hsTnT (<LoD)
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Detectable hsTnT (≥LoD but ≤99th percentile)
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Elevated hsTnT (≥14 ng/L)
Number of subjects: 882
Study: 24210368

Group type: EXPERIMENTAL
Intervention: 2% viscous lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23009738

Group type: EXPERIMENTAL
Intervention: Group intervention for 3 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: Individual intervention for 3 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both group and individual interventions
Number of subjects: 160
Study: 20799124

Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Desensitizer
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Fluoridation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (other methods)
Number of subjects: 102
Study: 18971406

Group type: EXPERIMENTAL
Intervention: CCDE program
Number of subjects: 228

Group type: COMPARATOR
Intervention: Agency-directed care
Number of subjects: 228
Study: 16583831

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/day plus MPA 2.5 mg/day (n = 7)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day (n = 13)
Number of subjects: 20
Study: 12503234

Group type: EXPERIMENTAL
Intervention: Integrated nutrition program
Number of subjects: 119

Group type: COMPARATOR
Intervention: Comparison communes (control)
Number of subjects: 119
Study: 10195603

Group type: EXPERIMENTAL
Intervention: 45-min portion-size estimation training session
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (34 subjects not trained)
Number of subjects: 110
Study: 7552059

Group type: EXPERIMENTAL
Intervention: Empirical titration of electrical stimulus for ECT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dose predictive methods from two different ECT equipment instruction manuals
Number of subjects: 0
Study: 2316883

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (3 mg/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 30
Study: 6444861

Group type: EXPERIMENTAL
Intervention: Lotion with hydrocortisone acetate ('Actinac')
Number of subjects: 44

Group type: COMPARATOR
Intervention: Lotion without hydrocortisone acetate
Number of subjects: 44
Study: 30773191

Group type: EXPERIMENTAL
Intervention: Injection of 3 to 9 ml of iodined PolyEthylene Glycol (PEG) hydrogel
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard clips only (control group)
Number of subjects: 42
Study: 31322589

Group type: EXPERIMENTAL
Intervention: Elgydium Protection caries toothpaste used for brushing teeth twice a day for 6 months
Number of subjects: 29

Group type: COMPARATOR
Intervention: Toothpastes with fluoride of the first generation (control group)
Number of subjects: 29
Study: 28683939

Group type: EXPERIMENTAL
Intervention: Scoring balloon pre-dilation before drug-coated balloon (DCB) therapy
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard DCB therapy
Number of subjects: 252
Study: 25125442

Group type: EXPERIMENTAL
Intervention: Wii Sports™ for arm rehabilitation
Number of subjects: 18
Study: 23932219

Group type: EXPERIMENTAL
Intervention: Multistrain preparation of lactobacilli and bifidobacteria (6 × 10^10 organisms, one per day for 21 days)
Number of subjects: 1493

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1493

Group type: EXPERIMENTAL
Intervention: Multistrain preparation of lactobacilli and bifidobacteria
Number of subjects: 1493

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1493
Study: 22025742

Group type: EXPERIMENTAL
Intervention: Text messaging (SMS) for health education
Number of subjects: 143

Group type: COMPARATOR
Intervention: Pamphlets for health education
Number of subjects: 143
Study: 18452743

Group type: EXPERIMENTAL
Intervention: Problem-solving training
Number of subjects: 67

Group type: COMPARATOR
Intervention: Education-only control
Number of subjects: 67
Study: 16228108

Group type: EXPERIMENTAL
Intervention: Intra-articular tenoxicam 20 mg once weekly for 1-3 weeks
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Oral tenoxicam 20 mg/day for 3 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 69
Study: 14626186

Group type: EXPERIMENTAL
Intervention: Shenfu injection (SFI)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (surgical operation alone)
Number of subjects: 98
Study: 10658688

Group type: EXPERIMENTAL
Intervention: Stress Management Intervention (SMI)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Assessment only (SMI Control)
Number of subjects: 562
Study: 9305716

Group type: EXPERIMENTAL
Intervention: CsA-based quadruple induction therapy using an antilymphocyte globulin preparation (ATG)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Tacrolimus-based dual or triple immunosuppression
Number of subjects: 458

Group type: COMPARATOR
Intervention: CsA-based triple therapy
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: CsA-based quadruple induction therapy using an interleukin-2 receptor antibody (BT563)
Number of subjects: 458
Study: 8382131

Group type: EXPERIMENTAL
Intervention: Sinorphan (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3532209

Group type: EXPERIMENTAL
Intervention: Intracervical Prostaglandin E2 (0.5 mg in 2.5 ml triacetin-gel)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oxytocin infusion alone
Number of subjects: 100
Study: 29927822

Group type: EXPERIMENTAL
Intervention: Piezoelectric technique during septorhinoplasty
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Distortion product otoacoustic emission results postoperatively
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (nasal surgery without piezoelectric technique)
Number of subjects: 30
Study: 27671868

Group type: EXPERIMENTAL
Intervention: Double-low imaging protocol (80-100 kV, 200 mAs, iohexol 300 mg iodine/ml, 1-1.5 ml/kg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional CT protocol (120 kV, 200-300 mAs, iopamidol 370 mg iodine/ml, 1-1.5 ml/kg)
Number of subjects: 72
Study: 25359278

Group type: EXPERIMENTAL
Intervention: Person-centred care
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standardized care
Number of subjects: 266
Study: 23186297

Group type: EXPERIMENTAL
Intervention: Very mild injury (VMI) vignette
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Mild injury (MI) vignette
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Moderate-to-severe injury (MSI) vignette
Number of subjects: 551
Study: 21081261

Group type: EXPERIMENTAL
Intervention: Combined condition (access to an integrated eHealth system for breast cancer (CHESS) and phone conversations with a Human Cancer Information Mentor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-intervention groups (either access to CHESS or phone conversations with a Human Cancer Information Mentor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Internet-only group
Number of subjects: 0
Study: 18180639

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP) plus Ropivacain (ROP) once a week
Number of subjects: 36

Group type: COMPARATOR
Intervention: Gabapentin (GBP) alone
Number of subjects: 36
Study: 15805957

Group type: EXPERIMENTAL
Intervention: Thigh tourniquet (Group A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No tourniquet (Group B)
Number of subjects: 54
Study: 12713213

Group type: EXPERIMENTAL
Intervention: Recruitment strategies including mailings, flyers, radio announcements, and group presentations.
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Caregivers' reasons for participating: interest in health (56%), interest in diet/health (51%), believing the program would be fun for their child (46%).
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Girls' reasons for participating: program sounded like fun (70%).
Number of subjects: 210
Study: 10571703

Group type: EXPERIMENTAL
Intervention: Information expressed as number needed to treat (NNT)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Information expressed in relative terms
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (no information provided)
Number of subjects: 215
Study: 8703882

Group type: EXPERIMENTAL
Intervention: Argon green laser treatment (n = 79)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Krypton red laser treatment (n = 72)
Number of subjects: 78
Study: 2537795

Group type: EXPERIMENTAL
Intervention: Captopril (10 mg i.v. bolus followed by 10 mg/hr constant infusion)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Human ANF (99-126) infusion
Number of subjects: 6
Study: 776313

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maprotiline
Number of subjects: 0
Study: 30526742

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 5345

Group type: COMPARATOR
Intervention: Control vaccination
Number of subjects: 5345
Study: 28241830

Group type: EXPERIMENTAL
Intervention: Insecticide-treated clothing (ITC)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Untreated clothing (NTC)
Number of subjects: 234
Study: 25347418

Group type: EXPERIMENTAL
Intervention: SC + pharmaceutical medication management
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SC + psychological counselling
Number of subjects: 30

Group type: COMPARATOR
Intervention: SC (standard care)
Number of subjects: 30
Study: 22923258

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.1 μg/kg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.25 μg/kg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (Dexmedetomidine 0 μg/kg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 240
Study: 20940335

Group type: EXPERIMENTAL
Intervention: Betahistine (24 mg b.i.d.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 19959115

Group type: EXPERIMENTAL
Intervention: RF ablation
Number of subjects: 191

Group type: COMPARATOR
Intervention: Cryoablation
Number of subjects: 191
Study: 22353021

Group type: EXPERIMENTAL
Intervention: Wechsler Adult Intelligence Scale‐Fourth Edition (WAIS‐IV) administered at baseline and again either 3 or 6 months later
Number of subjects: 54
Study: 16021858

Group type: EXPERIMENTAL
Intervention: u-hCG (10,000 IU)
Number of subjects: 100

Group type: COMPARATOR
Intervention: r-hCG (250 microg)
Number of subjects: 100
Study: 12426913

Group type: EXPERIMENTAL
Intervention: Suctioned only
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Positioned and suctioned
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Positioned, manually hyperinflated and suctioned
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 18
Study: 9638029

Group type: EXPERIMENTAL
Intervention: 75 g.kg‐1 load
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 95 g.kg‐1 load
Number of subjects: 30
Study: 8032079

Group type: EXPERIMENTAL
Intervention: Tamoxifen (60 mg/die)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 2574550

Group type: EXPERIMENTAL
Intervention: Cetirizine (20 mg QD for two days)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg BID for 1 week)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 55891

Group type: EXPERIMENTAL
Intervention: Treated index group (patients with hidden psychiatric disorders)
Number of subjects: 1093

Group type: COMPARATOR
Intervention: Untreated control group (patients with hidden psychiatric disorders)
Number of subjects: 1093

Group type: EXPERIMENTAL
Intervention: Detected group of patients (those whose disorder was recognized)
Number of subjects: 1093

Group type: EXPERIMENTAL
Intervention: Patients with mild disorders
Number of subjects: 1093
Study: 29478378

Group type: COMPARATOR
Intervention: Plyometric conditioning
Number of subjects: 47

Group type: COMPARATOR
Intervention: Skill-based conditioning
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 27895845

Group type: EXPERIMENTAL
Intervention: 7-valent conjugate pneumococcal vaccine
Number of subjects: 496

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 496
Study: 23407260

Group type: EXPERIMENTAL
Intervention: Quilting sutures and suction drains (QS+DN group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Quilting sutures alone (QS group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Suction drains alone (DN group)
Number of subjects: 48